Trial · NCT05792176
Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study
NCT05792176, Not applicable, Completed, University of Texas at Austin
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study. Trials, record NCT05792176. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05792176
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study
- NCT number
- NCT05792176
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 29 participants, actual
- Lead sponsor
- University of Texas at Austin
- Conditions
Multiple Sclerosis, Pathologic Processes, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Demyelinating Diseases, Autoimmune Diseases, Immune System Diseases
- Interventions
- Music Training Intervention, Music Listening
- First posted
- 2023-03-31
- Last updated
- 2025-03-13
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Intervention Feasibility | Immediately post-intervention | Feasibility will be evaluated by tracking the percentage of participants screened and enrolled. |
| Primary | Intervention Feasibility | Immediately post-intervention | Feasibility will be evaluated by tracking the average number of participants enrolled monthly. |
| Primary | Intervention Feasibility | Immediately post-intervention | Protocol adherence will be evaluated by recording the average number of modules completed by participants. |
| Primary | Intervention Acceptability | Immediately post-intervention | Acceptability will be evaluated with semi-structured interview questions to understand the participant's perception of MTI delivery and content and the perceived impact. |
| Secondary | Mean Change from Baseline in Anxiety Scores at 12 weeks and 16 weeks | Immediately post-intervention and 1-month post-intervention | The Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Anxiety Short-Form 8a will be used. The minimum score is 8, and the maximum score is 40. Higher scores indicate more anxiety. |
| Secondary | Mean Change from Baseline in Depression Scores at 12 weeks and 16 weeks | Immediately post-intervention and 1-month post-intervention | The Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short-Form 8a will be used. The minimum score is 8, and the maximum score is 40. Higher scores indicate higher levels of depressive symptoms. |
| Secondary | Mean Change from Baseline in Stress Scores at 12 weeks and 16 weeks | Immediately post-intervention and 1-month post-intervention | The Perceived Stress Scale will be used. The minimum score is 0, and the maximum score is 40. Higher scores indicate more perceived stress. |
| Secondary | Mean Change from Baseline in Self-Efficacy Scores at 12 weeks and 16 weeks | Immediately post-intervention and 1-month post-intervention | The Chronic Disease Self-Efficacy Scale will be used. The minimum score is 6, and the maximum score is 60. Higher scores indicate more self-efficacy. |
| Secondary | Mean Change from Baseline in Quality of Life Scores at 12 weeks and 16 weeks | Immediately post-intervention and 1-month post-intervention | The Multiple Sclerosis Quality of Life Questionnaire will be used. The minimum score is 27, and the maximum score is 135. Higher scores indicate worse quality of life. |
| Secondary | Mean Change from Baseline in Sleep Disturbance Scores at 12 weeks and 16 weeks | Immediately post-intervention and 1-month post-intervention | The Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep disturbance Short-Form 6a will be used. The minimum score is 6, and the maximum score is 30. Higher scores indicate more sleep disturbance. |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Symbol Coding | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05792176
GET https://conductscience.org/api/trials/v1/NCT05792176/registered